Multiple Assemblies exist for SMTL entry 5skh
Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(3-fluorophenyl)pyrazol-3-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4-one; X-RAY DIFFRACTION 2.10 Å

SMTL ID
5skh.1
Ligands
ZINC ION; MAGNESIUM ION; CHLORIDE ION; 3-[1-(3-fluorophenyl)-1H-pyrazol-5-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4(1H)-one
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5skh.2
Ligands
ZINC ION; MAGNESIUM ION; PRASEODYMIUM ION; GLYCEROL; 3-[1-(3-fluorophenyl)-1H-pyrazol-5-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4(1H)-one
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5skh.3
Ligands
ZINC ION; MAGNESIUM ION; PRASEODYMIUM ION; 3-[1-(3-fluorophenyl)-1H-pyrazol-5-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4(1H)-one
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5skh.4
Ligands
ZINC ION; MAGNESIUM ION; 3-[1-(3-fluorophenyl)-1H-pyrazol-5-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4(1H)-one
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer